LYNK Pharmaceuticals Funding: $50M Raised, Series B (2021)

LYNK Pharmaceuticals is based in Hangzhou, China. It has raised $50M in total funding. Latest round: Series B.

LYNK Pharmaceuticals funding overview

LYNK Pharmaceuticals is based in Hangzhou, China. LYNK Pharmaceuticals has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for LYNK Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, New Alliance Capital, Hangzhou HEDA Biological Medicine Venture Capital Partnersh…, Legend Capital, Med-Fine Capital. 5 distinct backers are named across the disclosed rounds.

LYNK Pharmaceuticals at a glance

Total raised
$50M
Latest round
Series B
Latest round date
August 2021
Headquarters
Hangzhou, China
Notable investors
Lilly Asia Ventures, New Alliance Capital, Hangzhou HEDA Biological Medicine Venture Capital Partnersh…, Legend Capital, Med-Fine Capital

Frequently asked about LYNK Pharmaceuticals funding

How much has LYNK Pharmaceuticals raised?
LYNK Pharmaceuticals has raised $50M in total disclosed funding across the rounds on record.
Who has invested in LYNK Pharmaceuticals?
Lilly Asia Ventures, New Alliance Capital, Hangzhou HEDA Biological Medicine Venture Capital Partnersh…, Legend Capital, Med-Fine Capital are named among the investors backing LYNK Pharmaceuticals.
What was the latest LYNK Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in August 2021.
Where is LYNK Pharmaceuticals based?
LYNK Pharmaceuticals is based in Hangzhou, China.
When did LYNK Pharmaceuticals last raise?
The last disclosed LYNK Pharmaceuticals round closed in August 2021 at Series B.

Every LYNK Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Hangzhou at a similar stage.

Companies related to LYNK Pharmaceuticals (36)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades